U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07941167) titled 'Gapless ECG-Monitoring for Stroke Prevention by Atrial Fibrillation Detection (GEMS-PAF-randomized Trial) - A Multi-centre, Randomized Controlled Outcome Trial.' on Nov. 10.
Brief Summary: 1. What is the purpose of this clinical trial?
All of the participants in this trial have been diagnosed with a stroke or transitoric ischaemic attack within 72 hours of inclusion. Strokes are usually caused by a blood clot, which subsequently leads to a blockage of a blood vessel in the brain. In more than 20% of patients who have had a stroke or a transient ischemic attack (TIA, a temporary reduction in blood flow to the brain), atrial fibrilla...